Reference number : 033-2024-2025-Q1-820057, amendment number : , agreement type : O, recipient legal name : Aspect Biosystems Ltd., recipient country : CA, recipient province : BC, recipient city : Vancouver, recipient postal code : V5T4T5, program name english : SIF Stream3- Attraction, program name french : FIS Volet3- Attraction, program purpose english : -Encourage R&D that will accelerate technology transfer and commercialization of innovative products, processes and services;-Facilitate the growth and expansion of firms in Canada;-Attract and retain large scale investments to Canada; and-Advance industrial research, development and technology demonstration through collaboration between academia, non-profit organizations and the private sector., program purpose french : -favoriser les activités de R-D qui accéléreront le transfert de la technologie et la commercialisation de produits, de processus et de services novateurs ;-faciliter la croissance et l'expansion des entreprises au Canada ;-attirer et conserver des investissements de grande envergure au Canada ; et-faire progresser la recherche industrielle, le développement et la démonstration de technologies grâce à la collaboration entre les universitaires, les organisations à but non lucratif et le secteur privé., agreement title english : Project Podium: Establish a world-leading biomanufacturing facility & capabilities to advance and produce bioprinted tissue therapeutics in Canada, agreement title french : Projet Podium : Établir une installation de biomanufacturation de pointe pour avancer et produire des thérapeutiques tissulaires bioprintées au Canada., agreement number : 820057, agreement value : 49000000.0, agreement start date : 2024-10-04, agreement end date : 2047-07-31, description english : Project Podium: Establish a world-leading biomanufacturing facility & capabilities to advance and produce bioprinted tissue therapeutics in Canada, description french : Project Podium: Establish a world-leading biomanufacturing facility & capabilities to advance and produce bioprinted tissue therapeutics in Canada, expected results english : nan, expected results french : nan, additional information english : Agreement Type is PRC, 2023/24 to 2027/28,, additional information french : Agreement Type is PRC, 2023/24 à 2027/28,, owner organization : ic, owner organization title : Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada